BK
Highly rated in
11
conditions

Dr. Bruce R. Korf

The Department Of Genetics
Birmingham, AL
Highly rated in
11
conditions
Specialties:Pediatrics | Medical Genetics
Experience:43 Years
Clinical Trials:Currently Recruiting for 1 Trial
Accepts:New PatientsMedicare
Highly rated in
11
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Bruce R. Korf's experience treating your condition:
About Dr. Bruce R. Korf

Bruce Korf is a Pediatrics specialist and a Medical Genetics expert in Birmingham, Alabama. Korf has been practicing medicine for over 43 years and is highly rated in 11 conditions, according to our data. His top areas of expertise are Neurofibromatosis, Neurofibromatosis Type 1 (NF1), RASopathies, and Legius Syndrome. He is licensed to treat patients in Alabama. Korf is currently accepting new patients.

His clinical research consists of co-authoring 138 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Bruce R. Korf it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Bruce R. Korf accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
Call to see if your plan is accepted.
Locations
720 20th St S, Kaul Human Genetics Building Room 230, Birmingham, AL 35233
Other Locations
2000 6th Ave S, Floor 1, Birmingham, AL 35233
1600 7th Ave S, Birmingham, AL 35233
Background & Education
Graduate Institution
Js Weill Medical College, Cornell University, 1980
Specialties
Pediatrics
Medical Genetics
Licenses
Clinical Genetics in AL
Hospital Affiliations
UAB Hospital
USA Health University Hospital
Childrens Of Alabama
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials
A Phase II Trial of Poly-ICLC for Progressive, Previously Treated Low-Grade Gliomas in Children and Young Adults With Neurofibromatosis Type 1
Enrollment Status: Recruiting
Publish Date: February 04, 2022
Intervention Type: Drug
Study Drug: Poly ICLC
Study Phase: Phase 2
A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
Enrollment Status: Active, not recruiting
Publish Date: December 15, 2022
Intervention Type: Drug
Study Drug: Binimetinib
Study Phase: Phase 2
A Phase 1/2 Trial of the MEK Inhibitor Selumetinib and Bromodomain Inhibitor With Durvalumab (MEDI4736), a PD-L1 Antibody for Sarcomas Including Malignant Peripheral Nerve Sheath Tumors (NF112)
Enrollment Status: Not yet recruiting
Publish Date: December 02, 2022
Intervention Type: Drug
Study Drug: Selumetinib
Study Phase: Phase 2
Pilot Study of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) for Adults With Neurofibromatosis Type 1 (NF1) and Cutaneous Neurofibromas (CNF)
Enrollment Status: Active, not recruiting
Publish Date: September 10, 2022
Intervention Type: Drug, Other
Study Drugs: SelumetinibSelumetinib Sulfate
Study Phase: Phase 2
Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Enrollment Status: Active, not recruiting
Publish Date: January 12, 2022
Intervention Type: Drug
Study Drug: Crizotinib
Study Phase: Phase 2
A Study of INFUSE Bone Graft (Recombinant Human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis 1 (NF1)
Enrollment Status: Terminated
Publish Date: October 27, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Enrollment Status: Completed
Publish Date: November 17, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials -
138 Total Publications
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk.
Journal: Annual review of genomics and human genetics
Published: August 31, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
NR
Dr. Nathaniel H. Robin
Medical Genetics
Highly rated in
9
conditions
Medical Genetics

UAB Medicine

Childrens Of Alabama

1600 7th Ave S, 
Birmingham, AL 
 0.3 mi

Nathaniel Robin is a Medical Genetics expert in Birmingham, Alabama. Robin has been practicing medicine for over 34 years and is highly rated in 9 conditions, according to our data. His top areas of expertise are Trisomy 18, Coffin-Lowry Syndrome, 1p36 Deletion Syndrome, and Autosomal Cleft Palate. He is licensed to treat patients in Alabama. Robin is currently accepting new patients.

MD
Dr. Maria C. Descartes
Pediatrics | Medical Genetics
Highly rated in
10
conditions
Pediatrics
Medical Genetics

Department Of Genetics

1530 3rd Ave S, 
Birmingham, AL 
 0.5 mi

Maria Descartes is a Pediatrics specialist and a Medical Genetics expert in Birmingham, Alabama. Descartes has been practicing medicine for over 40 years and is highly rated in 10 conditions, according to our data. Her top areas of expertise are Miller Syndrome, Acrofacial Dysostosis Rodriguez Type, Treacher Collins Syndrome, and Acrodysostosis. She is licensed to treat patients in Alabama. Descartes is currently accepting new patients.

JL
Dr. Jeffrey D. Lebensburger
Hematology Oncology | Pediatrics | Pediatric Hematology Oncology
Highly rated in
7
conditions
Hematology Oncology
Pediatrics
Pediatric Hematology Oncology

Childrens Of Alabama

1600 7th Ave S, 
Birmingham, AL 
 0.3 mi

Jeffrey Lebensburger is a Hematologist Oncology specialist and a Pediatrics expert in Birmingham, Alabama. Lebensburger has been practicing medicine for over 20 years and is highly rated in 7 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. He is licensed to treat patients in Tennessee and Alabama. Lebensburger is currently accepting new patients.